KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) FCF Margin (2016 - 2025)

Historic FCF Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 21.74%.

  • West Pharmaceutical Services' FCF Margin rose 103600.0% to 21.74% in Q4 2025 from the same period last year, while for Dec 2025 it was 15.25%, marking a year-over-year increase of 57000.0%. This contributed to the annual value of 15.25% for FY2025, which is 57000.0% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' FCF Margin is 21.74%, which was up 103600.0% from 16.64% recorded in Q3 2025.
  • West Pharmaceutical Services' FCF Margin's 5-year high stood at 21.74% during Q4 2025, with a 5-year trough of 3.97% in Q1 2024.
  • For the 5-year period, West Pharmaceutical Services' FCF Margin averaged around 13.06%, with its median value being 12.84% (2024).
  • Per our database at Business Quant, West Pharmaceutical Services' FCF Margin crashed by -89600bps in 2021 and then skyrocketed by 103600bps in 2025.
  • West Pharmaceutical Services' FCF Margin (Quarter) stood at 11.54% in 2021, then surged by 66bps to 19.18% in 2022, then fell by -7bps to 17.81% in 2023, then tumbled by -36bps to 11.38% in 2024, then surged by 91bps to 21.74% in 2025.
  • Its last three reported values are 21.74% in Q4 2025, 16.64% for Q3 2025, and 13.29% during Q2 2025.